Autologous Dendritic Cell-Tumor Cell Immunotherapy for Metastatic Melanoma
Public ClinicalTrials.gov record NCT01875653. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase III, Randomized, Double-Blind, Multicenter Trial of Autologous Dendritic Cells and Irradiated Autologous Tumor Cells In Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) vs. Autologous Peripheral Blood Mononuclear Cells (PBMCs) In GM-CSF for The Treatment Of Metastatic Melanoma
Study identification
- NCT ID
- NCT01875653
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Lisata Therapeutics, Inc.
- Industry
- Enrollment
- 4 participants
Conditions and interventions
Conditions
Interventions
- Autologous Dendritic Cell-Tumor Cell Immunotherapy (DC-TC) Biological
- Autologous PBMCs in GM-CSF (MC) Biological
Biological
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 30, 2014
- Primary completion
- Dec 31, 2015
- Completion
- Dec 31, 2015
- Last update posted
- May 9, 2019
2014 – 2016
United States locations
- U.S. sites
- 18
- U.S. states
- 11
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Irvine | California | 92612 | — |
| Not listed | La Jolla | California | 92093 | — |
| Not listed | Los Angeles | California | 90033 | — |
| Not listed | Newport Beach | California | 92625 | — |
| Not listed | Orange | California | 92868 | — |
| Not listed | Santa Monica | California | 90404 | — |
| Not listed | Aurora | Colorado | 80045 | — |
| Not listed | Goshen | Indiana | 46526 | — |
| Not listed | Louisville | Kentucky | 40506 | — |
| Not listed | Marrero | Louisiana | 70072 | — |
| Not listed | Baltimore | Maryland | 21237 | — |
| Not listed | Hackensack | New Jersey | 07601 | — |
| Not listed | Cincinnati | Ohio | 45219 | — |
| Not listed | Easton | Pennsylvania | 18020 | — |
| Not listed | Philadelphia | Pennsylvania | 19107 | — |
| Not listed | Philadelphia | Pennsylvania | 19111 | — |
| Not listed | Knoxville | Tennessee | 37996 | — |
| Not listed | Dallas | Texas | 75251 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01875653, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 9, 2019 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01875653 live on ClinicalTrials.gov.